Sale!

TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonismdementia complex susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TRPM7 Gene Amyotrophic Lateral Sclerosis-Parkinsonism Dementia Complex Susceptibility Genetic Test is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify genetic mutations in the TRPM7 gene, which have been associated with an increased risk of developing a complex neurological condition encompassing amyotrophic lateral sclerosis (ALS), parkinsonism, and dementia. These conditions are characterized by progressive degeneration of nerve cells, leading to a wide range of symptoms including muscle weakness, movement disorders, and cognitive decline.

The test is conducted through a comprehensive analysis of the patient’s DNA to detect any alterations in the TRPM7 gene that may predispose them to these neurodegenerative diseases. This information is crucial for individuals with a family history of these conditions, as it can provide valuable insights into their risk profile and help in making informed decisions about their health care and management.

The cost of the TRPM7 Gene Susceptibility Genetic Test at DNA Labs UAE is 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify and interpret genetic variations associated with these complex conditions. By choosing to undergo this test, patients gain access to personalized genetic information that can play a significant role in their health and well-being, offering a proactive approach to managing potential neurological health risks.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex susceptibility to Genetic Test

At DNA Labs UAE, we offer the TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex susceptibility to Genetic Test at a cost of AED 4400.0.

Test Details

The TRPM7 gene is a gene that provides instructions for making a protein involved in the regulation of various cellular processes, including cell growth, differentiation, and death. Mutations in this gene have been associated with a range of neurological disorders, including amyotrophic lateral sclerosis-parkinsonism/dementia complex (ALS-PDC).

NGS (next-generation sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. This type of testing is particularly useful in cases where there is suspicion of a genetic disorder but the specific gene or genes involved are not known.

NGS genetic testing for the TRPM7 gene can help identify mutations that may be contributing to the development of ALS-PDC. This information can be used to guide treatment and management strategies for affected individuals and their families. However, it is important to note that not all individuals with ALS-PDC will have mutations in the TRPM7 gene, and not all individuals with mutations in this gene will develop ALS-PDC.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to.

Test Name TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonismdementia complex susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TRPM7 Gene Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to
Test Details

The TRPM7 gene is a gene that provides instructions for making a protein that is involved in the regulation of various cellular processes, including cell growth, differentiation, and death. Mutations in this gene have been associated with a range of neurological disorders, including amyotrophic lateral sclerosis-parkinsonism/dementia complex (ALS-PDC).

NGS (next-generation sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. This type of testing is particularly useful in cases where there is suspicion of a genetic disorder but the specific gene or genes involved are not known.

NGS genetic testing for the TRPM7 gene can help to identify mutations that may be contributing to the development of ALS-PDC. This information can be used to guide treatment and management strategies for affected individuals and their families. However, it is important to note that not all individuals with ALS-PDC will have mutations in the TRPM7 gene, and not all individuals with mutations in this gene will develop ALS-PDC.